Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 16 abstracts featuring new data across its approved cancer therapies at the 2025 American Society of ...

Taking steps now, while your plan may be fully funded or in surplus, can help protect those funding gains and help ensure ...